Partner Therapeutics, Inc.
Budget
€10 — €0
EP Access
0
accredited persons
Staff
2
0.2 FTE
EU Grants
None
Mission & Goals
Partner Therapeutics, Inc. (PTx), an integrated biotechnology company, focuses on development and commercialization of late-stage therapeutics to improve health outcomes in treatment of serious diseases and to develop host-directed therapeutic treatments from global health security threats. The company believes in delivering products and supporting medical teams with the purpose of achieving superior outcomes for patients and their families.
EU Legislative Interests
EU Preparedness Union Strategy and EU Stockpiling and Medical Countermeasures Strategies
Communication Activities
We have been working with the European Medicines Agency and recently received European Commission/EMA approval of one of our products for the treatment of Haematopoietic Acute Radiation Syndrome under Exceptional Circumstances. We plan to discuss preparedness and response with appropriate agencies including, but not limited to EMA, HERA and ECHO. We also plan to reach out to appropriate member state preparedness and response personnel/agencies to discuss. We attend conferences and plan to attend future conferences in the EU focused on Health Security, Radiation Preparedness and Response, radiation biology, chemical weapons treatments, sepsis, ARDS and other related topics. We also publish and/or support the publication by our scientific collaborators of manuscripts on our products, health security, radiation preparedness and response and CBRN threats and treatments.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
Partner Therapeutics Incorporated, located in Lexington USA, represents the parent company. The persons listed on this form with access to the registration are both employed under the parent company. Partner Therapeutics Limited is a subsidiary entity located in Dublin Ireland.
Organisation Members
Partner Therapeutics Ltd., Dublin, Ireland
Additional Information
We had very little activity in 2025.
Commissioner Meetings
No recorded meetings with EU commissioners.